Pregnancy Clinical Trial
Official title:
Evaluation of Hysterotomy Site After Open Fetal Surgery
This study is to review how the uterus heals after having open fetal surgery. Open fetal
surgery causes a scar perhaps two: one from the open fetal surgery and a second from delivery
by cesarean section; rarely, the same area of your uterus was used for both open fetal
surgery and delivery. From other studies of surgery performed on a uterus, some of the
uterine scars do not heal well. This study's intervention uses sterile saline to spread open
the inside of the uterus. The saline is slowly injected into the uterus using a catheter. An
ultrasound called a sonohysterogram is performed to take pictures of the uterus, its inside
and the walls of the uterus. In this way, the healed areas from the uterine surgery can be
seen with ultrasound and evaluated. This is performed at least 6 months after delivery.
Primary Outcome:
Measure the depth of the scar and location of the scar 6 months or longer after delivery.
This is an Investigator initiated, prospective study reviewing medical records and performing
a sonohysterogram on non-pregnant women at 6 or more months after delivery of an infant who
received open fetal repair.
An evaluation is completed at SSM Cardinal Glennon (CG), Fetal Care Institute (FCI) of a
woman who has decided to have open fetal surgery to complete a fetal repair before the infant
is born.
- After open fetal surgery participant will be monitored and delivered appropriately.
- After the infant is born investigators will review the mother's and infant's electronic
health records and FCI database records
- 6 months or more after delivery of an infant who has received open fetal repair the
participant will go to Saint Louis University (SLU) Care for a sonohysterogram to
evaluate the healing process.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
| Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
| Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
| Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
| Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
| Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
| Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
| Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
| Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
| Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
| Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
| Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
| Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
| Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
| Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
| Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
| Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
| Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
| Completed |
NCT02523755 -
Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia
|
Phase 4 |